15:58 IST
BSE
Management Change
Ishita Drugs & Industries Management Change
Ishita Drugs and Industries Limited has re-appointed Abha Agrawal as a Non-Executive Non-Independent Director, effective October 1, 2026.
Ishita Drugs & Industries Ltd
- Share price
- ₹81.99
- Market cap
- ₹24.52 Cr
- Revenue (annual)
- ₹14.66 Cr
- Net profit (annual)
- ₹0.78 Cr
- P/E (TTM)
- 34.7×Sector 47.4×
- Promoter holding
- 50.04%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Other Announcement 1Management Change 1Financial Results 1Debt & Borrowing 1Board Meeting Date 1Annual General Meeting 1
Time
1 announcement with these filters